The positive effects of R-7050 in terms of improving poststroke hyperglycemia and glucose intolerance can likely be attributed to the inhibitory effects on TNFR/IKK and TNFR/JNK signaling. The gene discussed is MAPK8; the disease is Hyperglycemia.